Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Postlicensure Observational Safety Study of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) Administered in Routine Use to Infants and Toddlers

NCT01128426 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01128426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01128426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Postlicensure Observational Safety Study of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) Administered in Routine Use to Infants and Toddlers
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
June 30, 2010
Completion date
June 30, 2013
Enrollment
53,902 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pneumococcal disease